Serum calprotectin as an inflammatory marker in psoriatic arthritis patients: Relation to disease activity and musculoskeletal ultrasound findings
Egyptian journal of Immunology · 01.07.2024 · 31 (03) · 140-149
DOI: 10.55133/eji.310314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Egyptian journal of Immunology, online erschienen am 01.07.2024. Verfasst von Magdeldin Hamada. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. The use of inflammatory markers can be disappointing in PsA since they are elevated in only about half of the patients. This study aimed to measure serum calprotectin level in PsA patients and to assess its association with disease activity in PsA (DAPSA) and musculoskeletal ultrasound findings. The study included 50 PsA patients and 30 controls. All subjects underwent medical history, musculoskeletal examination, hand and wrist joints ultrasound, and laboratory assessment. The mean age of patients was 41.04±11.8 years with female: male ratio of 3:2, and the median duration of arthritis 2 years (1-4 years) and DAPSA 25 years (3-84 years). The most common finding in patients by ultrasound was synovial hypertrophy in wrist joint (32%) followed by hand joints (28%). Patients' serum calprotectin level was significantly higher (174.2 ng/ml; ranged 127.5-282.6 ng/ml) than controls 41.4 ng/ml; ranged 19.9-59.8 ng/ml) (p106.4 ng/ml (with sensitivity 98%, and specificity 86.6%; p=0.001) and predicted synovial hypertrophy in hand joints at cutoff >258.9 ng/ml (with sensitivity 71%, and specificity 83%). There was a significant relation between serum calprotectin with synovial hypertrophy (p=0.004), osteophytes (p
Zitieren
APA
Hamada, M. (2024). Serum calprotectin as an inflammatory marker in psoriatic arthritis patients: Relation to disease activity and musculoskeletal ultrasound findings. Egyptian journal of Immunology, 31(03), 140-149. https://doi.org/10.55133/eji.310314
Vancouver
Hamada M. Serum calprotectin as an inflammatory marker in psoriatic arthritis patients: Relation to disease activity and musculoskeletal ultrasound findings. Egyptian journal of Immunology. 2024;31(03):140-149. doi:10.55133/eji.310314
BibTeX
@article{Hamada2024,
author = {Hamada, Magdeldin},
title = {Serum calprotectin as an inflammatory marker in psoriatic arthritis patients: Relation to disease activity and musculoskeletal ultrasound findings},
journal = {Egyptian journal of Immunology},
year = {2024},
volume = {31},
number = {03},
pages = {140--149},
doi = {10.55133/eji.310314}
}
EUVIMED